Joint Staff Chief Information Officer Lt. Gen. Brad Shwedo on increased cybersecurity during COVID19
Joint Staff Chief Information Officer Lt. Gen. Brad Shwedo on increased cybersecurity during COVID19
Joint Chiefs of Staff Chief Information Officer Lt. Gen. Brad Shwedo discusses ways the Department of Defense is working to mitigate risk, reduce attack vectors and increase cybersecurity of our networks during a COVID-19 during a press conference, April 13, 2020.Watch the entire press briefing here:
https://www.youtube.com/watch?v=4NTposZ3LyA
Stay up to date with the latest DoD response efforts to COVID-19:
https://www.defense.gov/Explore/Spotlight/Coronavirus/
Subscribe to our channel for the latest news on the Joint Staff and visit our website to learn more about our mission: http://www.jcs.mil
Connect with us on social media:
http://www.facebook.com/thejointstaff
http://twitter.com/thejointstaff
http://www.youtube.com/thejointstaff
http://www.flickr.com/photos/thejointstaff
http://www.instagram.com/thejointstaff/
https://www.linkedin.com/company/thejointstaff
Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.